Status:
RECRUITING
Therapeutic Adherence of Multiple Sclerosis Patients
Lead Sponsor:
Lille Catholic University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to assess the role of sociocognitive and interpersonal factors in the therapeutic adherence of multiple sclerosis patients. This study will provide a better understanding of ...
Detailed Description
Multiple sclerosis is a chronic and progressive disease that affects young adults (between 20 and 40 years old), impacting significantly the patients quality of life. The adherence to therapy affects...
Eligibility Criteria
Inclusion
- Multiple sclerosis defined according to McDonald criteria;
- Already undergone or beginning substantive treatment (self-managed, excluding treatment administered in hospital)
- Aged ≥ 18 years;
- Given the informed consent form.
Exclusion
- Severe cognitive impairment (score below the 5th percentile);
- Any associated neurological pathology or serious or chronic somatic disease (cancer);
- Being under a legal protection measure.
Key Trial Info
Start Date :
January 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 18 2025
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT04837352
Start Date
January 18 2022
End Date
October 18 2025
Last Update
March 26 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU DE Bordeaux
Bordeaux, France
2
Hôpital Saint-Vincent de Paul
Lille, France, 59000
3
Hôpital Saint-Philibert
Lomme, France, 59462
4
CHRU de Strasbourg
Strasbourg, France